LGND - CIK 0000886163
LIGAND PHARMACEUTICALS INC trades as LGND and has a market capitalization of $4.97 B, making it the #1388 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $268.09M, up 60.4% from the prior year and net income of $124.45M. This page tracks LIGAND PHARMACEUTICALS INC through 2,226 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years LIGAND PHARMACEUTICALS INC's revenue grew from $108.97M to $268.09M, a compound annual growth rate of 10.5%. Net profit margin expanded from -1.5% to 46.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Proxy materials | DEFA14A | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-04 |
Ligand Pharmaceuticals Incorporated - Ligand to Participate in June Investor Conferences
Ligand Pharmaceuticals Incorporated - Ligand Reports First Quarter 2026 Financial Results
Ligand Pharmaceuticals Incorporated - Ligand to Participate in May Investor Conferences
Ligand Pharmaceuticals Incorporated - Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Webcast: Live and replay webcasts of the call are available here .
The largest companies sharing LIGAND PHARMACEUTICALS INC's SEC industry classification (pharmaceutical preparations).
LIGAND PHARMACEUTICALS INC (LGND) has a market capitalization of $4.97 B as of 2026-06-10, ranking #1388 among US-listed companies.
LIGAND PHARMACEUTICALS INC reported revenue of $268.09M for fiscal year 2025, an increase of 60.4% year over year.
Yes. LIGAND PHARMACEUTICALS INC reported net income of $124.45M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.